MODAFOCUS 300

What is MODAFOCUS 300?

MODAFOCUS 300 is a modern pharmaceutical agent belonging to the pharmacological group of psychostimulants and nootropic drugs, the main active ingredient of which is modafinil. The drug is designed to correct pathological daytime sleepiness and maintain a high level of alertness in patients with sleep-wake cycle disorders. The manufacturer of MODAFOCUS 300 is the pharmaceutical company Kachhela, which specializes in the production of high-quality generics and innovative nootropic agents. The release form is oral tablets with a dosage of 300 mg, which allows providing a long-lasting therapeutic effect throughout the day. The drug is used exclusively as prescribed by a physician, as it requires a thorough assessment of the patient's condition and determination of the optimal dosing regimen.

Modafinil, which is the active component of MODAFOCUS 300, was first synthesized in the late 20th century and has since been actively studied in global medical practice. Unlike classical amphetamine-class psychostimulants, modafinil has a significantly lower potential for addiction development and less pronounced cardiovascular side effects. The mechanism of action of the drug is associated with its effect on certain areas of the brain responsible for regulating wakefulness and attention. MODAFOCUS 300 is not a classic "memory booster," but rather a modulator of the functional state of the central nervous system, which allows the patient to maintain clarity of thought and productivity in high-load situations. The drug is dispensed by prescription and requires a responsible attitude toward the treatment process.

In clinical practice, MODAFOCUS 300 has established itself as an effective agent for patients suffering from narcolepsy, obstructive sleep apnea, and shift work sleep disorder. It is important to understand that the drug does not replace full sleep, but only helps the body maintain the required level of activity during periods when sleep is impossible or disrupted. The therapeutic effect develops gradually and depends on the individual characteristics of the patient's metabolism. Taking MODAFOCUS 300 should be accompanied by maintaining a healthy lifestyle and regular monitoring of health status by a physician.

What is MODAFOCUS 300 prescribed for?

The main indications for the use of MODAFOCUS 300 are conditions accompanied by pathological daytime sleepiness, which significantly reduces the patient's quality of life. Primarily, the drug is prescribed to patients with a confirmed diagnosis of narcolepsy — a chronic neurological disorder characterized by sudden attacks of sleep during the day. In such cases, MODAFOCUS 300 helps stabilize the wakefulness cycle and reduce the frequency of uncontrolled falling asleep episodes. The efficacy of the drug in narcolepsy is confirmed by numerous clinical studies demonstrating a significant improvement in patients' daytime activity.

The second important group of indications is obstructive sleep apnea, in which patients suffer from chronic fatigue and sleepiness due to repeated breathing pauses during night sleep. MODAFOCUS 300 is used as an adjunctive agent in the complex therapy of this condition, especially when the primary treatment (for example, CPAP therapy) does not fully eliminate daytime sleepiness symptoms. The drug allows patients to maintain working capacity and avoid dangerous situations associated with falling asleep while driving a vehicle or performing professional duties. It is important to emphasize that MODAFOCUS 300 does not cure apnea itself, but only corrects its consequences in the form of excessive sleepiness.

A separate category of patients consists of individuals with shift work sleep disorder, when the body's biological clock does not have time to adapt to night shifts or frequent flights. In such cases, MODAFOCUS 300 helps maintain an appropriate level of concentration and reaction speed during periods when the body is physiologically tuned for sleep. The drug may be recommended by a doctor for short-term use in professional situations requiring prolonged alertness, but such use must be strictly justified. In any case, the decision to prescribe MODAFOCUS 300 is made exclusively by a qualified specialist after a thorough examination of the patient.

Composition and active components of MODAFOCUS 300

The main active substance of MODAFOCUS 300 is modafinil at a dosage of 300 mg per tablet, which provides a pronounced and long-lasting wakefulness-promoting effect. Modafinil belongs to the class of so-called "eugeroics" — substances that promote alertness without the pronounced psychostimulatory effect characteristic of amphetamines. The mechanism of action of modafinil lies in its selective effect on hypothalamic structures of the brain, in particular on neurons that produce orexin — a neuropeptide responsible for regulating the sleep-wake cycle. In addition, modafinil increases dopamine concentration in the synaptic cleft by blocking its reuptake, which contributes to improved cognitive functions and a feeling of alertness.

Excipients included in MODAFOCUS 300 tablets ensure the stability of the drug, the proper release rate of the active substance, and convenience of use. These include microcrystalline cellulose, starch, magnesium stearate, and other pharmaceutically acceptable fillers that have no independent therapeutic action. Thanks to the balanced composition, MODAFOCUS 300 tablets dissolve quickly in the gastrointestinal tract, and modafinil reaches peak concentration in blood plasma in approximately 2–3 hours after administration. The elimination half-life of the drug is about 12–15 hours, which allows it to be taken once daily without the need for frequent repeated dosing.

It is important to note that modafinil is metabolized mainly in the liver with the participation of the cytochrome P450 enzyme system, in particular the CYP3A4 isoenzyme. This means that the rate of drug elimination may change in patients with impaired liver function or with the concomitant use of drugs affecting the activity of this enzyme system. Therefore, before starting MODAFOCUS 300 therapy, the doctor must evaluate the patient's liver condition and analyze potential drug interactions. Individual response to modafinil may vary, so the dosage and administration regimen are always selected individually.

Dosage of MODAFOCUS 300

The standard recommended dose of MODAFOCUS 300 for adult patients is 300 mg once daily, usually in the morning or one hour before the start of a work shift. Such a dosing regimen ensures the maintenance of the required level of alertness throughout the entire period of active work without significantly affecting nighttime sleep. For patients with narcolepsy and obstructive sleep apnea, the daily dose may be divided into two doses — in the morning and at noon; however, such a decision is made exclusively by the doctor. Exceeding the recommended dose does not lead to a proportional increase in the therapeutic effect, but significantly increases the risk of side effects.

The duration of the treatment course with MODAFOCUS 300 is determined individually depending on the diagnosis, severity of symptoms, and patient's response to therapy. In most cases, the drug is used long-term, especially for chronic conditions such as narcolepsy, where constant correction of daytime sleepiness is required. However, the doctor periodically evaluates the appropriateness of continuing therapy, analyzing the benefit-to-potential-risk ratio for the specific patient. For individuals with shift work sleep disorder, MODAFOCUS 300 may be prescribed in short courses or as needed, which avoids the development of tolerance.

Dose adjustment of MODAFOCUS 300 may be required for elderly patients, as well as individuals with impaired liver or kidney function. In such cases, the doctor may recommend an initial dose of 150 mg (half a tablet) with subsequent titration until the optimal therapeutic effect is achieved. Patients with severe hepatic impairment are usually prescribed reduced doses of the drug due to slowed modafinil metabolism. Self-changing the dosage without consulting a doctor is strictly prohibited, as this can lead to unpredictable health consequences.

How to take MODAFOCUS 300 correctly?

MODAFOCUS 300 should be taken orally with a sufficient amount of water, regardless of food intake. However, to achieve a more predictable therapeutic effect, it is recommended to take the tablet at the same time every day, preferably in the morning. Taking the drug with food may slightly delay the absorption rate of modafinil, but does not significantly affect the overall bioavailability of the active ingredient. It is important not to chew or crush the tablet, as this may disrupt the uniform release of the active component and lead to undesirable fluctuations in the drug concentration in the blood.

If a patient misses a dose of MODAFOCUS 300, the drug should be taken as soon as possible if there is enough time remaining before the next scheduled dose. In the event that the time for the next dose is approaching, the missed tablet should be skipped and the regular dosing schedule resumed without doubling the dose. Taking MODAFOCUS 300 in the afternoon or evening may cause difficulty falling asleep and disrupt the natural sleep cycle. Therefore, patients are recommended to plan the administration of the drug so that its peak concentration falls during the period of active performance.

During MODAFOCUS 300 therapy, alcohol consumption and other central nervous system depressants should be avoided, as this may lead to unpredictable interactions and reduced treatment efficacy. Patients who drive vehicles or operate machinery need to be cautious at the start of therapy until their individual reaction to the drug is established. MODAFOCUS 300 is not a substitute for full sleep, so patients are recommended to adhere to a healthy rest schedule and avoid chronic sleep deprivation. Before starting the drug, it is imperative to consult a doctor and report all existing medical conditions and medications being taken.

Side effects of MODAFOCUS 300

The most common side effects of MODAFOCUS 300 are headache, nervousness, anxiety, and insomnia, which usually occur at the start of therapy and diminish with continued treatment. Some patients may experience gastrointestinal disorders such as nausea, dry mouth, decreased appetite, or diarrhea. These symptoms are generally mild to moderate in nature and do not require discontinuation of the drug; however, their appearance should be reported to the doctor. To reduce the severity of side effects, the doctor may recommend a temporary dose reduction or adjustment of the administration time.

Uncommon side reactions of MODAFOCUS 300 include tachycardia, increased blood pressure, palpitations, and chest pain. Patients with pre-existing cardiovascular diseases require particularly careful monitoring during therapy, as modafinil can place additional strain on the heart. In rare cases, serious skin reactions may develop, including Stevens-Johnson syndrome and toxic epidermal necrolysis, which require immediate discontinuation of the drug and medical attention. Isolated cases of psychiatric disorders, such as hallucinations, mania, or depression, have also been reported, especially in patients with a psychiatric history.

Patients should consult a doctor immediately upon the appearance of any unusual symptoms, especially if accompanied by skin rash, swelling of the face or limbs, difficulty breathing, or impaired consciousness. An individual's response to MODAFOCUS 300 can vary significantly, so it is important to closely monitor one's condition throughout the treatment period. Regular doctor visits allow for the timely detection of potential problems and adjustment of therapy according to patient needs. One should not ignore even seemingly minor changes in well-being, as they may be early signs of serious complications.

Contraindications of MODAFOCUS 300

Absolute contraindications to the use of MODAFOCUS 300 are hypersensitivity to modafinil or any auxiliary component of the drug, as well as a history of severe allergic reactions to drugs of this group. The drug is not prescribed to patients with uncontrolled arterial hypertension, severe cardiac arrhythmias, and other serious cardiovascular diseases, as modafinil can trigger an exacerbation of these conditions. MODAFOCUS 300 is contraindicated in psychomotor agitation, severe anxiety disorders, and psychoses, as the drug may worsen the symptoms of these conditions. Also, the drug is not used in patients with severe hepatic impairment due to the risk of modafinil accumulation in the body.

Relative contraindications requiring special caution are ischemic heart disease, recent myocardial infarction, unstable angina, and cerebrovascular disorders. For patients with these conditions, MODAFOCUS 300 can only be prescribed after a thorough assessment of the benefit-risk ratio, with mandatory monitoring of the cardiovascular system function. The drug is not recommended for use during pregnancy, as data regarding the safety of modafinil for the fetus are limited, and some studies have reported an increased risk of congenital malformations. Women of childbearing potential should use reliable methods of contraception during therapy with MODAFOCUS 300.

MODAFOCUS 300 is not prescribed to children and adolescents under 18 years of age, as the safety and efficacy of the drug in this age group have not been established. Elderly patients may require a dose reduction due to age-related changes in liver and kidney function, as well as increased sensitivity to the action of psychoactive substances. Before starting MODAFOCUS 300 therapy, the doctor must conduct a comprehensive examination of the patient, including an evaluation of liver, kidney, cardiovascular system function, and mental status. Only after this is a decision made regarding the possibility of using the drug and the optimal dosing regimen determined.

Interaction of MODAFOCUS 300 with other drugs and alcohol

MODAFOCUS 300 can interact with many medications, so before starting therapy, the patient must inform the doctor about all drugs they are taking. Concomitant use of modafinil with hormonal contraceptives requires special attention, as modafinil accelerates the metabolism of estrogens and progestins in the liver, which can reduce their efficacy. Patients using oral contraceptives are recommended to use additional contraceptive methods during MODAFOCUS 300 therapy and for one month after its completion. Modafinil can also reduce the efficacy of cyclosporine, theophylline, and certain antiviral drugs.

Alcohol consumption during MODAFOCUS 300 therapy is not recommended, as ethanol can enhance the side effects of the drug on the central nervous system and increase the risk of unpredictable reactions. In addition, alcohol disrupts the natural sleep cycle, which contradicts the main goal of treatment — normalisation of the sleep-wake schedule. Patients taking MODAFOCUS 300 should exercise caution when driving vehicles and operating machinery, especially at the start of therapy until their individual reaction to the drug is established. Although modafinil usually improves concentration, in some patients it can cause dizziness or impaired coordination, making driving dangerous.

Where to buy MODAFOCUS 300 in Ukraine

MODAFOCUS 300 is available in Ukraine through a network of licensed pharmacies and specialized online platforms selling medicines in accordance with current legislation. Since the drug belongs to prescription-only remedies, a prescription from a doctor confirming the validity of modafinil use in a specific clinical case is required for its purchase. This approach ensures patient safety and prevents the uncontrolled use of psychoactive substances. The manufacturer Kachhela ensures proper product quality and compliance with international standards of pharmaceutical production.

Storage conditions for MODAFOCUS 300 require keeping the drug in a dry place, protected from light, at a temperature not exceeding 25 degrees Celsius, out of the reach of children. The shelf life is usually 24 months from the date of manufacture, after which the use of the drug is prohibited. Many pharmacy chains offer convenient home delivery of MODAFOCUS 300 or the possibility of pre-ordering via online services, which is especially convenient for patients taking the drug long-term. Before purchasing the drug, it is recommended to check availability and current prices at several pharmacies, as well as to make sure the seller holds the appropriate license.